Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (8) , 6580-6587
- https://doi.org/10.1074/jbc.m408375200
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Central core disease mutations R4892W, I4897T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ releaseBiochemical Journal, 2004
- Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptorBiochemical Journal, 2004
- Dantrolene – A review of its pharmacology, therapeutic use and new developmentsAnaesthesia, 2004
- The Pore Region of the Skeletal Muscle Ryanodine Receptor Is a Primary Locus for Excitation-Contraction Uncoupling in Central Core DiseaseThe Journal of general physiology, 2003
- Altered Ryanodine Receptor Function in Central Core Disease Leaky or Uncoupled Ca2+ Release Channels?Trends in Cardiovascular Medicine, 2002
- Spectroscopic Monitoring of Local Conformational Changes during the Intramolecular Domain−Domain Interaction of the Ryanodine ReceptorBiochemistry, 2002
- Dantrolene Sodium Can Increase or Attenuate Activity of Skeletal Muscle Ryanodine Receptor Calcium Release ChannelAnesthesiology, 1996
- Conformational changes in the foot protein of the sarcoplasmic reticulum assessed by site-directed fluorescent labelingBiochemistry, 1992
- Dantrolene Dose Response in Awake ManAnesthesiology, 1983
- Effect of dantrolene sodium on calcium movements in single muscle fibresNature, 1974